Orchestra BioMed Holdings Cash Flow Statement (2021-2026) | OBIO

Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-0.13M-0.12M-0.12M-5.36M-7.89M-10.45M-10.16M-11.90M-16.96M-22.02M-12.20M-15.80M-25.19M-17.62M-16.10M-19.38M-21.57M-20.54M6.39M-24.75M
Depreciation and Depletion (Quarter)
0.05M0.05M0.05M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.08M0.08M
Share-based Compensation (Quarter)
0.07M0.08M2.09M0.86M1.49M0.13M1.59M0.92M2.59M0.14M10.70M-0.31M2.96M8.30M0.36M0.47M11.00M
Gains from Investment Securities (Quarter)
0.14M1.01M-0.04M0.23M0.29M
Cash from Operations (Quarter)
-0.04M-0.13M-0.03M-5.32M-7.96M-7.26M-8.74M-14.38M-10.49M-10.28M-10.97M-13.11M-10.21M-13.70M-13.54M-16.62M-15.53M-14.55M-2.27M-22.17M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
1.06M1.06M1.06M0.64M0.59M0.33M0.36M0.23M0.11M0.05M0.33M0.32M0.08M
Amortization of Deferred Charges (Quarter)
0.13M0.14M-0.14M0.44M0.15M0.16M0.16M-0.36M0.05M0.17M0.28M0.15M0.15M0.15M0.15M-0.23M0.06M
Depreciation & Amortization (CF) (Quarter)
0.05M0.05M0.05M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.08M0.08M0.08M0.08M0.08M0.08M0.09M
Change in Working Capital
Change in Receivables (Quarter)
-0.04M0.00M0.02M-0.02M0.10M-0.09M0.01M-0.03M0.01M0.04M-0.04M-0.00M-0.01M-0.03M0.04M-0.01M
Change in Inventory (Quarter)
-0.04M0.10M0.20M-0.05M-0.04M-0.05M-0.04M0.01M-0.03M-0.04M0.16M-0.06M-0.04M0.05M0.18M-0.06M-0.03M
Change in Account Payables (Quarter)
-0.02M-0.02M-267.000.10M0.07M0.11M0.10M
Change in Accured Expenses (Quarter)
0.01M0.08M0.03M0.20M0.47M1.62M1.06M-1.79M0.78M0.67M0.49M-1.28M3.73M1.23M-0.71M-0.20M1.09M3.41M0.57M-3.06M
Other Working Capital Changes (Quarter)
-0.07M0.56M-0.01M-0.04M1.50M-0.77M-0.27M0.32M0.06M-0.11M0.59M0.53M-0.04M-0.11M-0.14M-0.59M0.48M
Investing Activities
Capital Expenditures (Quarter)
0.05M0.27M0.22M0.05M0.04M0.03M0.02M-0.00M0.01M0.11M0.07M0.11M0.11M0.03M-0.06M0.09M0.18M
Change in Acquisitions & Divestments (Quarter)
51.49M37.11M29.61M29.18M10.61M17.23M16.01M16.39M9.51M7.95M4.74M
Cash from Investing Activities (Quarter)
-0.05M-0.47M-0.22M-63.38M-43.53M8.12M12.95M33.15M5.86M10.42M0.56M-3.75M13.00M16.36M-38.58M-17.71M10.32M
Financing Activities
Other financing activities (Quarter)
0.07M0.01M0.04M0.00M0.02M56.79M0.02M0.17M0.05M0.09M0.03M
Cash from Financing Activities (Quarter)
24.76M86.08M-2.50M-5.09M56.82M0.09M0.00M-10.70M0.02M0.17M15.04M13.95M-0.30M-0.43M76.40M12.66M5.53M
Additional items
Change in Cash (Quarter)
-0.04M-0.13M-0.03M19.39M77.64M-9.98M-77.21M-1.09M-2.29M2.67M11.48M-7.24M0.39M1.89M-3.34M-3.91M0.40M23.26M-7.32M-6.32M
Free Cash Flow (Quarter)
-0.04M-0.13M-0.03M-5.37M-8.23M-7.48M-8.80M-14.42M-10.52M-10.30M-10.97M-13.12M-10.31M-13.77M-13.64M-16.73M-15.56M-14.49M-2.36M-22.35M
Net Cash Flow (Quarter)
-0.04M-0.13M-0.03M19.39M77.64M-9.98M-77.21M-1.09M-2.29M2.67M11.48M-7.24M0.39M1.89M-3.34M-3.91M0.40M23.26M-7.32M-6.32M